Immunomodulation Therapy for Primary Prevention of Urinary Tract Infections in Patients With Spinal Cord Injury During First Rehabilitation: a Randomized Controlled Pilot Study
Latest Information Update: 09 Nov 2023
At a glance
- Drugs Escherichia-coli-strains (Primary)
- Indications Urinary tract infections
- Focus Therapeutic Use
- Acronyms UROVAXOM-P
Most Recent Events
- 03 Nov 2023 Status changed from active, no longer recruiting to completed.
- 08 Jun 2023 Planned primary completion date changed from 1 Jun 2023 to 1 Sep 2023.
- 08 Jun 2023 Status changed from recruiting to active, no longer recruiting.